Should You Buy Injective in 2025?

Why trust HelloSafe?

At HelloSafe, our expert has been closely monitoring the performance of the Injective cryptocurrency for over three years. Every month, tens of thousands of users across New Zealand trust us to analyse market trends and identify the most promising investment opportunities. Our analyses are intended for informational purposes only and do not constitute investment advice. In line with our ethical standards, HelloSafe has never purchased Injective or received any compensation from entities related to its ecosystem.

Injective in brief

How much does 1 Injective cost?

The price of Injective is up this week. As of today, INJ is trading at NZ$20.29, reflecting a 5.8% increase in the past 24 hours and a 3.8% gain over the past week. Injective’s current market cap stands at approximately NZ$2.03 billion, ranking #61 globally, with an average 3-month daily trading volume of about NZ$156 million. There are 97.7 million INJ tokens in circulation, representing a market dominance of 0.14%. With solid momentum but inherent volatility, Injective remains an asset to monitor for both traders and long-term investors in New Zealand.

Our full review of the crypto Injective

After a rigorous review of the latest trends and three-year performance for Injective (INJ), our proprietary algorithms have synthesized on-chain indicators, technical signals, market data, and a granular view of the competitive environment. Drawing from a basket of leading analytics, the evolving macro backdrop and token-specific data sets converge to outline a refreshed narrative for INJ in the next cycle. So, why could Injective once again become a strategic entry point for the next wave of DeFi innovation in 2025?

Performance & Market Context

Recent Price Evolution

Injective is coming off a strongly positive momentum, currently trading at $12.41 USD with a 24-hour increase of +5.8%, a +3.8% gain in the last week, and an impressive +22.4% performance over the past month. On a year-over-year basis, INJ has delivered +57.7% returns, signaling robust interest and traction amid a broader altcoin recovery phase. Notably, INJ remains -76.4% off its all-time high ($52.62, March 2024), highlighting both significant upside potential and inherent volatility typical of crypto midcaps.

Recent Positive Developments

• Strategic partnerships (Google Cloud, Deutsche Telekom, T-Mobile).
• Major mainnet upgrades (Lyora).
• Expansion into tokenized equities (iAssets) and on-chain Forex markets.
• Explosive ecosystem growth: 100+ projects, $40bn+ traded on Helix DEX, 500,000+ community members.

These advances have not only lifted near-term price performance but have also structurally strengthened the project's value proposition.

Macro/Sectoral Backdrop

2025 is shaping up to be broadly constructive for digital assets. Persistently high inflation, ongoing institutional interest, and the normalisation of blockchain-native financial primitives across the TradFi and DeFi divide fuel an increasingly tech-forward investment climate. Layer 1 projects with a proven track record, strong tokenomics, and real utility—such as Injective—are especially well-positioned to benefit from the sector rotation back toward DeFi innovation and scalability.

Technical Analysis

Crypto Indicators & Structure

• RSI (14d): 51 (neutral zone); room for both upside breakout and mean reversion if inflows resume.
• MACD: Slightly below the signal line, reflecting a technical reset post-rally—a potential accumulation zone for medium-term investors.
• Moving Averages: INJ currently trades just below the 20-day MA ($12.82, serving as immediate resistance), with strong supports at the 50 ($11.53) and 100-day ($10.52) averages. The 200-day MA ($16.23) marks a critical resistance for a potential trend flip.

Support Zones & Bullish Reversal Signals

Solid base-building appears underway above the main support at $11.70, with buying pressure evident on dips toward the 50 and 100-day moving averages. A decisive break above $12.82 could unlock momentum towards the major psychological barrier at $16.23 and beyond. Overall, the medium-term market structure remains constructive, with repeated higher lows suggesting latent bullish sentiment.

Short/Mid-Term Momentum

With bullish on-chain flows, stable technical indicators, and a supportive macro tailwind, INJ stands on the verge of a trend resumption—contingent on sustained ecosystem news and inflows of smart capital as the DeFi narrative regains traction.

Fundamental Analysis

Growing Adoption & Strategic Partnerships

• Over 100 projects now build on Injective, spanning DeFi, derivatives, and tokenized assets.
• Partnerships with blue-chip names (Google Cloud, Deutsche Telekom, T-Mobile) broaden INJ’s institutional reach and validate its long-term vision.
• Helix DEX surpassing $40bn in lifetime volume underscores real-world traction.

Relative Valuation

• Market Cap: $1.24bn (well-positioned among Layer 1 blockchains, yet with substantial headroom versus top DeFi competitors).
• Circulating Supply: Just under 100m INJ—scarcity compounded by a robust weekly token burn (60% of all protocol fees), already reducing total supply by over 7m tokens.

Structural Strengths

• Technological Edge: Ultra-fast (0.6 second block time, 25,000+ TPS), on-chain order books resistant to MEV, and seamless interoperability (23+ supported chains).
• Community: 500K+ members, highly engaged and bullish sentiment (86%).
• Differentiation: First-mover advantage in orderbook-based DeFi, native support for tokenized real-world assets, and advanced cross-chain capabilities.

Volume, Liquidity & Dominance

With a 24-hour trading volume of $95m+ and widespread exchange listings, INJ enjoys strong market liquidity, promoting healthy price discovery and stable spreads. Ranking #61 on CoinMarketCap, INJ is firmly entrenched among the large-caps, securing both visibility and investor confidence.

Positive Catalysts & Forward-Looking Drivers

• Upcoming protocol upgrades (Lyora and further MultiVM extensions) to boost speed and developer flexibility.
• Integration of new DeFi/NFT assets and the roll-out of on-chain Forex, expanding addressable markets.
• Staking and governance continue to gain adoption, with 51.5M INJ staked (+10% in 2024).
• Recent inflows from institutional players and validator upgrades via partnerships.
• Regulatory signals turning slightly more constructive for compliant DeFi in select jurisdictions.

Investment Strategies (Time Horizons)

Short-Term

• Opportunity to enter on technical pullbacks near $11.70–$12.00, with upside catalysts tied to protocol announcements or broader crypto rallies.
• Potential volatility spikes offer tactical entry points for active traders, especially ahead of expected ecosystem news or asset listings.

Medium-Term

• Accumulation ahead of major protocol upgrades (notably the anticipated Lyora execution layer enhancements).
• Benefiting from momentum, as the token burn and staking rates pressure available supply while usage continues to ramp.

Long-Term

• INJ’s unmatched deflationary mechanics, expanding product suite, and growing market share in tokenized real-world assets and orderbook DeFi position it as a core Layer 1 bet for a multi-cycle view.
• Ideal positioning lies in taking advantage of wider market corrections or “crypto winter” periods to build exposure, with an eye on high-conviction holding through sectoral upswings.

Injective Price Projection Table

Is Now the Time to Consider Injective?

Injective presents a compelling blend of technical momentum, institutional validation, and unique deflationary design—fundamentals that justify renewed investor focus as DeFi and tokenized assets enter a new high-growth phase. With meticulously engineered protocol improvements, expanding cross-chain integrations, and a highly engaged community, Injective appears poised to outpace many of its Layer 1 peers.

Key strengths to highlight:

• Robust deflationary tokenomics and weekly burns reducing supply.
• High-throughput, ultra-fast blockchain architecture.
• Market-leading orderbook DEX, strong developer ecosystem, and blue-chip partnerships.
• Strong liquidity and superior real-world product-market fit.

While volatility is non-negligible, the convergence of cutting-edge tech, growing revenue capture, and impending protocol upgrades suggest INJ could soon initiate a new upward leg. The pathway to performance, supported by sound fundamentals and rising institutional adoption, signals that INJ may well be entering a new accumulation zone deserving of close consideration.

Injective remains a high-volatility cryptocurrency that offers dynamic investment opportunities—but demands rigorous risk management. The recent uptick in price signals Injective’s tendency for swift, powerful moves; yet evolving macro factors call for selective positioning. Technical levels to watch are $11.70 NZD as immediate support and $16.23 NZD as major resistance. The upcoming Lyora protocol upgrade, forecasted for Q2 2025, could serve as a pivotal catalyst for Injective’s future trajectory.

How to buy Injective?

It’s simple and secure to buy Injective (INJ) online through a regulated platform, even if you’re new to crypto investing. There are two main options: buying INJ “on the spot”, where you own the real token stored in your wallet, or trading INJ with a CFD (Contract for Difference), where you speculate on its price movement without actually owning the asset. Each method comes with specific fees and benefits. Below, you’ll find a detailed comparison of the leading platforms available for NZ investors to help you choose the right one for your goals.

Spot Purchase

Buying Injective on the spot means you actually own real INJ tokens, which you can hold in your exchange or personal wallet. Platforms typically charge a fixed commission per transaction, often from 0.1% to 1%, plus a standard NZD transaction fee (around NZ$8 per trade is common).

Example

If INJ is priced at NZ$20.20 per token, NZ$1,000 will buy you about 49.5 INJ (allowing NZ$8 for fees). You directly hold the coins in your wallet.

• ✔️ Gain scenario: If the INJ price rises by 10%, your portfolio is now worth NZ$1,100.
• Result: NZ$100 gross profit, or +10% on your investment.

Trading via CFD

Trading Injective CFDs means you don’t actually own INJ; instead, you take a position on its price direction. CFDs offer leverage (amplifying your exposure) and let you profit from both rising and falling prices. Fees typically include a spread (the difference between buy/sell prices) and an overnight funding rate if you hold your position overnight.

Example

You enter a NZ$1,000 CFD trade on INJ using 5× leverage. This gives you NZ$5,000 effective market exposure.

• ✔️ Gain scenario: If INJ increases by 8%, your position gains 8% × 5 = 40%.
• Result: NZ$400 gross profit on your NZ$1,000, excluding spread and overnight fees.

Final Advice

Comparing fees and conditions between platforms is essential before investing, as these can vary and significantly impact your returns. Your choice depends on your investment objectives and experience: holding INJ directly suits those who want real ownership and long-term growth, while CFD trading may fit those seeking higher (but riskier) short-term moves. You’ll find a detailed platform comparison lower on this page to help you select the best option for your needs.

Our 7 tips for buying Injective

The latest news about Injective

Injective has shown a strong price recovery with a 3.8% gain over the last week. This improvement sits within a one-month performance of +22.4%, signaling renewed market confidence and suggesting a constructive momentum, further underlined by a bullish 86% community sentiment. Current support and resistance levels ($11.70 and $12.40) closely align with technical trading activity, and the present RSI of 50.98 indicates neither overbought nor oversold conditions—appealing to New Zealand-based investors seeking medium-term stability after the notable volatility seen in earlier periods.

The introduction of the iAssets platform enabling 24/7 tokenized stock trading marks a positive innovation milestone. With tokenized access to major global equities like Apple, Tesla, and Microsoft, Injective presents unique utility and diversification for New Zealand’s increasingly crypto-curious investors, especially as domestic investment platforms seek exposure to offshore assets without regulatory complexity. This is particularly relevant given local users’ appetite for borderless financial tools and may indirectly increase interest in Injective’s ecosystem within New Zealand.

Injective’s ongoing technical and ecosystem upgrades, especially the recent Lyora Mainnet enhancement, have boosted network security and performance. This upgrade aligns with global industry standards—such as support for MultiVM and seamless cross-chain compatibility—bolstering institutional credibility and decreasing perceived risk for downstream use in New Zealand-facing DeFi applications and DEXs. The infrastructure improvements are especially constructive given the strict operational expectations of Australasian institutional participants.

Strategic partnerships with major global telecom and cloud players reinforce institutional trust and growth prospects. Collaborations with Google Cloud, Deutsche Telekom, and T-Mobile broaden development resources and infrastructure reliability. These alliances are viewed favorably by financial analysts in New Zealand, where institutional due diligence increasingly demands traceable support from internationally recognized technology and telecom leaders—a signal that reduces counterparty and operational risk.

Injective’s deflationary tokenomics and record-breaking token burn rate remain key strengths within the broader crypto market. The protocol’s model, with 60% of platform fees used for weekly token buybacks and burns, has now destroyed over 7 million INJ tokens—the highest burn rate industry-wide. Combined with a recent 10.34% increase in tokens staked, this drives scarcity, rewards long-term holders, and aligns with the preferences of risk-adjusted investors and funds in New Zealand seeking robust, deflation-linked value accrual mechanisms in digital asset portfolios.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.